Study of the Clinical Efficacy of Autologous SCT in Patients With Critical Limb Ischemia

NCT01311011 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 26

Last updated 2011-12-13

No results posted yet for this study

Summary

Phase II Prospective Study of the Clinical Efficacy of Autologous SCT in patients with Critical Limb Ischemia

Conditions

  • Critical Limb Ischemia

Interventions

PROCEDURE

SCT

SCT

Sponsors & Collaborators

  • King Faisal Specialist Hospital & Research Center

    lead OTHER

Principal Investigators

  • H Al-Zahrani, M.D. · KFSH & RC

Eligibility

Min Age
14 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-11-30

Countries

  • Saudi Arabia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01311011 on ClinicalTrials.gov